Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
8.93
-0.71 (-7.37%)
At close: Jul 13, 2026, 4:00 PM EDT
8.93
0.00 (0.00%)
Pre-market: Jul 14, 2026, 4:01 AM EDT
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 106 employees as of March 31, 2026. The number of employees increased by 2 or 1.92% since the number was last reported on December 31, 2025.
Employees
106
Change
2
Growth
1.92%
Revenue / Employee
n/a
Profits / Employee
-$821,415
Market Cap
433.89M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 106 | 2 | 1.92% |
| Dec 31, 2025 | 104 | 15 | 16.85% |
| Dec 31, 2024 | 89 | 46 | 106.98% |
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cabaletta Bio | 158 |
| C4 Therapeutics | 104 |
| Verastem | 102 |
| Prelude Therapeutics | 79 |
| Prothena Corporation | 67 |
| Zura Bio | 40 |
| Ovid Therapeutics | 23 |
ARTV News
- 13 days ago - Artiva Biotherapeutics Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
- 20 days ago - Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 5 weeks ago - Artiva Biotherapeutics Transcript: Status update - Transcripts
- 5 weeks ago - Artiva Biotherapeutics Press release: Status update - Filings
- 5 weeks ago - Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026 - TheFly
- 5 weeks ago - Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today - GlobeNewsWire
- 5 weeks ago - Artiva Biotherapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire